Growing Number of Heart Failure Incidences to Augment Demand for Dilated Cardiomyopathy Medications

Dilated cardiomyopathy has led to an increase in heart failures worldwide among adults and children also giving rise to need for heart transplant. Dilated cardiomyopathy can develop between the ages of 20 and 40 years, genetic inheritance being the most common factor affecting 30%-40% of the DCM patients globally. Due to the increasing cases of heart failures, the demand for dilated cardiomyopathy drugs is expected to increase as the need for blockbuster drugs in developed countries is becoming evident. 

According to a report published by Transparency Market Research, the global dilated cardiomyopathy therapeutics market is expected to witness a negative CAGR of -7% from 2014 to 2020. The global dilated cardiomyopathy market was valued at US$651 mn in 2013 and is projected to decrease to US$328.6 mn by 2020. 

Browse Report: 

http://www.transparencymarketresearch.com/dilated-cardiomyopathy-market.html

How can an increase in heart failure cases help drug manufacturers to develop innovative and advanced therapeutics?

According to a study, in every one million children across the globe, six are diagnosed with dilated cardiomyopathy. It is found commonly among children who are under the age of 2 years. There has also been a substantial increase in the number of heart failures among adults as well, leading to a global rise in the demand for dilated cardiomyopathy therapeutics. Of the overall congestive heart failures that occur each year, DCM comprises 30%-40%. Due to this, several leading companies have introduced clinical trials and invested for the development of therapeutics for dilated cardiomyopathy. 

For instance, Cincinnati Children’s Heart Institute announced a breakthrough development on 19 May, 2016 where genetically inherited heart diseases can be diagnosed and treated with the help of biomechanics and stem cells. Similar breakthroughs are underway in the field of dilated cardiomyopathy drugs to help in the growth of the market with better techniques and medications. 

What factors are responsible for the negative growth of the dilated cardiomyopathy therapeutics market?

 DCM drugs segment has no drug that has been approved by FDA till date. The drugs used for the treatment of dilated cardiomyopathy and congestive heart failure are same and have no distinct formulation. DCM drugs are reported to have side effects and this has thus affected revenues from DCM therapeutics substantially. The use of devices and gene therapy that provide enhanced relief without any side effect has highly restrained the dilated cardiomyopathy therapeutics market growth globally.

However, companies in the DCM drug market along with research organizations are working on the approval of aldosterone antagonists combined with ARBs or ACE. It is expected that these drugs will play a positive role in reducing the progress of Duchenne muscular dystrophy. This approval will help in the acceleration of sales of DCM drugs as aldosterone antagonists are one of the main additives in the formulation of DCM medications. 

The increase in genericization activities of DCM drugs will also provide manufacturers with opportunities to improve their product position in the global market and also witness a positive growth of the DCM drugs market.

North America dominated the DCM drugs market in 2013 due to the demand for branded drugs and increasing heart failure cases. Asia Pacific is projected to be the fastest growing market for DCM followed by the Rest of the World owing to the per capita income increase, and improving economic standards in the region. Some of the key players operating in the global DCM drugs market are Celladon Corporation, Novartis International AG, Vericel Corporation, Sanofi S.A., AstraZeneca plc, and GlaxoSmithKilne plc.

Rising Construction Activities Worldwide to Shape Growth of the Global Mattress Market

Changing lifestyles have transformed various optional commodities into necessities. One such thing is a mattress. Mattress come in a wide range of product varieties based on styles, sizes, and a range of firmness. Post-recession economic stability across developed countries and rising disposable incomes in developing countries are positively influencing the market. An affluent consumer is willing to pay more for premium mattresses that assure greater comfort and excellent sound sleep. All these factors are likely to keep the global mattress market on the growth track.

Flourishing Hospitality Industry to Drive Demand for Mattresses: Rising consumer spending on leisure activities can be attributed to the increased average income. This trend has registered an augmented visits to hotels. In addition, a rise in the construction of new hotels is surging the demand for mattresses. These factors are contributing to the substantial growth of the global mattress market.

Research Report: http://www.transparencymarketresearch.com/mattress-market.html

Rising number of renovation activities and new homeowners to Propel Sales of Mattresses: The sales of new homes and renovation of old houses are notifying an upward trend across developed and developing countries. In developed countries of Europe and North America, this trend can be attributed to stabilizing economies post the economic depression of 2008. In developing regions such as Latin America, Asia Pacific, and regions of Africa, emerging economies play a central role in the rise of domestic construction activities. Home renovation activities have become more frequent owing to rising disposable incomes of the homeowners in the region. Another factor attributing to the rise in the domestic construction activities in the region is the large-scale migration from rural to urban areas. These factors are contributing to the global mattress market as a high impact driver.

Increasing Prevalence of Sleep Disorders to Boost Uptake of Mattresses: Mattresses are gaining a worldwide popularity due to cost effectively and large scope of innovation. The demand for mattresses is anticipated to propel owing to growing prevalence of a number of health concerns associated with uncomfortable sleeping surfaces and sleep disorders.

Common Masses and Battery Manufacturers to Acknowledge Battery Recycling to Conserve Environment

The latest trends state rising awareness for the conservation of environment and benefits of recycling. These trends are likely to fuel the growth of global battery recycling services market. Moreover, the growing cognizance of battery manufacturers regarding the health and environmental hazards of used batteries coupled with rising strictness of government regulations related to reducing the emission of greenhouse gases has given a great push to the demands of battery recycling services.

Growing Awareness of Environmental Hazards to Play an Imperative Role

The various toxics present in a battery are cadmium, lithium, lead, mercury, manganese, nickel, and zinc can potentially contaminate the market if not disposed of properly. The hazardous environmental and health conditions pertaining to the critical nature of these batteries have compelled manufacturers and governments to frame various schemes for battery recycling.

Large Number of Spent Batteries Disposed from Automotive Industry to Fuel Action

Batteries are used in various sectors such as automotive, appliances, and electronics. The high yield of disposed lead acid batteries from vehicles has fuelled the demand for battery recycling services. Also, the extraction of these batteries is operationally easier. As a result, the automotive sector is the leading segment in terms of sourcing the global battery recycling market.

Research Report: http://www.transparencymarketresearch.com/battery-recycling-market.html

High Participation of Government Organizations to Propel Battery Recycling Services

Europe is one of the most lucrative markets due to the growing demand for battery recycling services. Common masses in the region strongly support the recycling and proper disposal of the used batteries, thereby encouraging the growth of battery recycling market. The growth of this market is further supported by government organizations that are working towards the reduction of hazardous emissions from the batteries.

North America and Asia Pacific are the two rapidly growing regions in the global battery recycling market owing to stringent environmental regulations by several government institutions. In addition, the increased applications of batteries can also be attributed as one of the factors bolstering the growth of the global battery recycling market.

Rising Geriatric Population will be a Pivotal Trend for Growth of Pain Management Therapeutics Market

The Rising incidence of chronic diseases can be attributed to aging population, increased population undergoing surgeries, changing lifestyles, and gradually changing environmental conditions. Researchers report that presently about 20% of the world’s population suffers from chronic pain. This accelerates the need for addressing chronic pain with a sophisticated and effective solution. As a result, the growth of the global pain management therapeutics market in the past few years has triggered and is poised to drive the market at an effective CAGR in the coming years.

High Prevalence of Chronic Diseases to Intensify the Growth of Pain Management Therapeutics Market

The number of patients suffering from chronic pain is increasing at an alarming rate. This has escalated the demand for pain management therapeutics. The mounting cases of cancer and diabetes further contributed to the expansion of global pain management therapeutics market. According to a report by World Health Organization (WHO), the number of new cancer cases is anticipated to grow by almost 70% across the globe. A surge in the number of cases of chronic back pain owing to rising geriatric population and hectic lifestyles will also enable lucrative growth of the global pain management therapeutics market.

Research Report: http://www.transparencymarketresearch.com/pain-management-therapeutics.html

Pain Management Industry to Benefit from Old Demographics

The rising prevalence of diseases such as arthritis, depression, diabetic neuropathy, epilepsy, joint or bone pain, and nerve damage can be attributed to the increasing geriatric population. Various studies suggest that by 2050, the age of nearly 22% of the projected global population will be more than 65. This demographic trend towards the older generation will lead to a notable rise in the demand for numerous pain management therapeutics, thereby boosting the growth of global pain management therapeutics market.

Favorable Regulatory Measures to Propel the Consumption of Pain Management Therapeutics

Regulatory framework plays a crucial role in the successful development, approval, and commercialization of numerous drugs in the pain management therapeutics sector. The intervention of regulatory firms that favor the deployment of instruments for the improved diagnosis and treatment of chronic pain and employment of methods for improvement of efficiency, will help global pain management therapeutics market in maintaining a substantial growth rate.

Rising Demand for Premium Confectioneries Spurs the Growth of Sugar Confectionery Market

Sugar confectioneries are consumed by most income groups in Asia Pacific and Latin America and their market is expanding owing to the growing demand for sweet snacks and confectionery foods. A surge in the demand for toffees, boiled sweets, fondant, premium chocolates, and marshmallows is driving the sugar confectionery market in these two regions.

The market presents a wide scope for experiment, making it an opportunity-laden market. During recent times, growth in the application of medicated confectionery in the development of drugs for conditions such as allergies, cold, cough, and respiratory tract congestion has been witnessed. These developments are likely to drive the sugar confectionery market.

Reduced Prices of Sugar in APAC Keep Sugar Confectioneries Market on Growth Track

Key companies are investing huge capital in the lucrative market of APAC, leading to a reduction in the prices of sugar. The gradual decrease in prices is anticipated to propel the demand for sugar confectionery products, particularly in rural areas. In urban areas, the rapidly developing retail industry and rising disposable income are likely to bolster the growth of sugar confectionery market. The rising demand for premium confectionery products in these areas is also anticipated to give a great push to the market. 

Research Report: http://www.transparencymarketresearch.com/asia-pacific-latin-america-sugar-confectionery-market.html

In China, the growth of sugar confectionery market can be attributed to the growing trend of using confectionery as gifts on festive occasions and purchasing power of the customers. The Asia Pacific sugar confectionery market, comprising India, China, South Korea, and Japan, is influenced by the strong presence of many local players.

Augmented Demand for Innovative Confectionery Products in LATAM Benefits Sugar Confectioneries Market

The Latin America sugar confectionery market is characterized by the growing sugarcane industry in countries such as Argentina, Brazil, and the rest of LATAM. Growing preference for healthy and quality products has increased the scope of innovation in sugar confectioneries. Growing consumption of pastilles, nougats, gums, and candies as alternatives to chocolate is anticipated to drive the sugar confectionery market in LATAM. Moreover, the presence of many local players is likely to reduce the cost of sugar confectionery products.

High Incidences of Hearing Losses Induces High Demand for Hearing Aids

Hearing aids are devices that provide assistance to the partially deaf people by amplifying the sound signals. The hearing aids market is anticipated to boom owing to the increasing number of hearing impairment cases. However, a report by WHO indicates that the hearing aid production globally could hardly meet 10% of the total need in 2015.

Growing Geriatric Population Fuels the Demand for Hearing Aids: With a rising global population crossing the age of 60, the risk of hearing impairment is also increasing. The sales of hearing aids are positively influenced by the increasing geriatric population across the globe. Moreover, features such as proper insulation and easy-fit on the ear make hearing aid a popular choice amongst the old-age population.

Government initiatives Back the Growth of Hearing Aids Market: An increase in the level of awareness in the patients regarding the hearing aids in the last few years can be attributed to government campaigns and incentives aimed at curbing the incidence of hearing loss. The technological advancements are also playing a significant role in augmenting the sales of hearing aids. The introduction of rechargeable hearing aids with quick charging features and long lasting battery life will bolster the growth of the market. 

High Prevalence of Hearing Impairment among Adults Open Avenues for Research: Various studies report that nearly 6% of the global population suffers from hearing loss, out of which approximately 95% are adults. The incidences of hearing impairment are increasing at an alarming rate. This opens avenues for development of new products.

Research Report: http://www.transparencymarketresearch.com/hearing-aid-market.html

Opportunities for the growth of the market are most conducive in Europe and has registered the highest number of users of hearing aids. However, rising investment in the healthcare infrastructure and high unmet medical needs are likely to make Asia Pacific market lucrative.

Advent of Cognitive Learning to Revolutionize Development of E-Clinical Solution Software

E-clinical solution software comprises programs intended to make the process of data management in the global healthcare sector easier than can be done with conventional methods. The healthcare industry generates a massive volume of patient data every day, which requires careful storage in a way that also allows easy access for future use. The confidentiality of patient data also makes the storage system used for healthcare data crucial. This has driven the demand for digital data storage systems in the last few years and several major players have adopted various types of web-based e-clinical solution software to boost their productivity. 

According to Transparency Market Research, the global market for e-clinical solution software was valued at US$3 bn in 2014. Exhibiting a robust growth rate of 13.80% from 2014 to 2020, the market is expected to rise to a valuation of US$6.8 bn. 

How is cognitive learning impacting the global e-clinical solution software market?

One of the major points discussed at last month’s Digital Health Summer Summit in San Francisco was the potential applications of cognitive learning programs in the healthcare industry. While smart data logging and tracking software is becoming common in healthcare applications, the advent of cognitive learning in the field represents a crucial milestone for the industry.

Cognitive learning programs have the ability to not only organize and secure data, but also to come up with insights based on the data and to modify the conclusions when more data is added. This presents a major advancement for the healthcare industry owing to the increased accuracy and reliability cognitive learning solutions provide. 

Which is the most popular delivery mode for e-clinical solution software?

By delivery mode, the demand for web-based e-clinical solution software dominates the global market. However, cloud-based delivery of e-clinical solution software is expected to become increasingly popular in the coming years. While web-based data storage revolutionized the healthcare industry by demonstrating the benefits of digitization, cloud-based data storage represents the logical next step of outsourcing data storage services. Cloud-based delivery of e-clinical solution software allows the end users to focus their resources on improving their core operations, which has driven the demand for cloud services. 

Of the major end users of e-clinical solution software, the pharmaceutical industry took up the leading share in the global market in 2014. The consistent need for precise data in the pharmaceutical industry has made the sector a prominent end user of e-clinical solution software, with the increasing number of clinical trials expected to provide a major boost to the demand for e-clinical solution software in the coming years. However, clinical research organizations (CROs) are another major end user segment of the global e-clinical solution software market and are likely to exhibit the fastest growth in demand in the 2014-2020 forecast period.

Browse Research Release: 

http://www.transparencymarketresearch.com/pressrelease/global-e-clinical-solution-software-market.htm

What does the increasing number of clinical trials in Asia Pacific signify for the e-clinical solution software market?

Currently, North America is the global leader in the e-clinical solution software market and holds a share of close to 60% due to the strong presence of the pharmaceutical industry in the region. Nevertheless, the increasing population in Asia Pacific is expected to result in an increase in the demand for e-clinical solution software, with North America’s share expected to drop to about 55% by 2020. Several pharmaceutical and life sciences companies are setting a firm foothold in rampant Asia Pacific economies, where the demand for pharmaceutical products is likely to grow significantly in the coming years.

Increasing Research into Longer Lasting Peptide Therapeutics Set to Bear Fruit

Peptides are short-chain amino acids used therapeutically in the treatment and management of several diseases, including major killers such as diabetes. Peptides are differentiated from proteins by the length of their amino acids; proteins have longer amino acid chains than peptides. Peptides such as insulin have been in therapeutic use for a long time and have helped drive investment in research into the therapeutic efficacy of peptides. Due to the growing investment in the sector, peptide therapeutics are becoming increasingly important in the global healthcare sector. 

Browse Full Market Research Report: 

http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

According to Transparency Market Research, the global peptide therapeutics market is expected to exhibit a low yet steady 2.8% CAGR between 2014 and 2020. The market’s valuation is expected to rise from US$18.9 bn in 2013 to a projected US$23.7 bn by the end of the forecast period. Apart from the established therapeutic uses of peptides, their potential use in the treatment of various cancers, neurological disorders, hematological disorders, and cardiovascular and respiratory disorders is expected to be crucial for the market’s growth in the forecast period. 

How important will the growing prevalence of diabetes be for the peptide therapeutics market?

Despite the increasing research into the use of peptides in the treatment of various other diseases, the use of insulin in diabetes management remains the key application of peptide therapeutics. Diabetes has not shown any signs of slowing down since insulin became the first therapeutically used peptide; in fact, its prevalence has grown rapidly in the last few decades, as the increasing prosperity in developed economies has made various risk factors for diabetes increasingly accessible to the average consumer. The disease is expected to remain a global healthcare concern in the coming years, driving the market for advanced insulin products.

Apart from the use of insulin in diabetes management, what is the key driver for the peptide therapeutics market?

The increasing innovation of advanced peptide therapeutics is another key driver for the global peptide therapeutics. As the infrastructure for clinical research into peptide therapeutics becomes more refined, the use of high-precision methods and tools has allowed market giants to come up with safe and effective peptide therapeutics. Due to the increasing consumer satisfaction brought about by technological progress, collaboration between biotech and pharmaceutical companies is expected to be a prominent feature of the global peptide therapeutics market in the coming years.

A key advancement in the field of peptide therapeutics is the innovation of stable peptide molecules that aren’t degenerated by the body as quickly as conventional peptides. The conventional mode of delivering peptide therapeutics has involved permeability enhancement, which comprises various techniques to ease the entry of the peptide into the vascular network around the digestive tract. However, most slow-acting peptide therapeutics fail to achieve significant bioavailability through this procedure. The promising recent development of a phase-II GLP-1 analog that has a circulating half life of around one week by Novo Nordisk could open the doors for peptide therapeutics to be used on a wider scale in the treatment of several other diseases.

Which region presents the most lucrative opportunities for producers of peptide therapeutics?

Even though North America and Europe currently account for a majority share in the global peptide therapeutics market, the future of the market is expected to be dominated by Asia Pacific. The medical research sector in Asia Pacific has undergone significant development in the last few years, and the high prevalence of diabetes in Asian races means peptide therapeutics are not an entirely novel field.

Government Support Crucial for Widespread Adoption of Stem Cell Therapy

Stem cells are a type of human cells that give rise to the various types of cells found in the human body. Stem cells hold the potential to evolve into various types of human tissue, which has led to a growing acknowledgement of the obvious medical potential of this property. Stem cell therapy is becoming increasingly common in the treatment of various diseases and the increasing research in the field is expected to further drive the medical applications of stem cells in the coming years.

According to Transparency Market Research, government support is expected to be crucial in the global stem cells market’s expected rise from a 2013 valuation of US$26.3 bn to a valuation of US$119.5 bn by 2018. The market is expected to exhibit a robust 24.2% CAGR between 2012 and 2018.

Download Complete Healthcare Analytical Brochure: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132

What are the major advances in the field of stem cells and their medical application?

In July 2016, a joint Dutch-Canadian research effort succeeded in discovering a viable method of increasing the amount of stem cells obtained from cord blood. Cord blood, which is blood from the placenta, contains a relatively small amount of stem cells per unit. The method formulated in the research allows researchers to increase the amount of stem cells obtained from cord blood, making this is a crucial advancement in the field of stem cell therapy. 

The team discovered that mirR-125a, a microRNA, is responsible for the property of stem cells to self-renew. This genetic ‘switch’ remains activated in stem cells but is inactivated in the progenitor cells formed from the division of stem cells. Success in activating this switch would result in self-sustaining production of stem cells, which will be a major boost for the global stem cell therapy market.

In April this year, a research team at McMaster University in Hamilton, Ontario, discovered the protein responsible for the growth and development of blood stem cells. The Musashi-2 protein could be the key to helping thousands of patients of various blood disorders, as understanding the ambit of the protein could allow researchers to increase the number of viable stem cells available for therapeutic use.

What are some of the major drivers for the stem cells market?

The key driver for the global stem cells market is the increasing government support across the world. As widespread incorporation of stem cell therapy allows a nation to significantly improve the overall healthcare scenario, countries in North America and Western Europe have provided solid support to stem cell research. The acceptance of stem cell therapy in emerging regions is still lagging behind due to the lack of advanced medical infrastructure to adopt stem cell therapy, but the steady improvement of the healthcare sector in countries such as India and China is likely to be a major growth driver for the global stem cells market.

The increasing prevalence of neurodegenerative disorders is another major driver for the global demand for stem cells. Neural tissue can’t be regenerated or replaced as easily as structural tissues, and the ability of stem cells to develop into human cells provides the perfect avenue for treatment of neurodegenerative conditions.

High Occurrence of Unintended Pregnancy Drives the Demand for Oral Contraceptives Globally

The global oral contraceptive market has gained much prominence over years owing to a high incidence of unwanted pregnancies and various awareness programs run by governments and NGOs. Contraceptive pills, also known as birth control pills, are used in changing the hormonal cycles and preventing pregnancy. The rise in the concept of family planning has fueled the growth of the global oral contraceptive market. Moreover, the advantages of the oral contraceptive method over abortion to get rid of unwanted pregnancy helped the global oral contraceptive market in maintaining a positive growth rate.

Similarity in Composition with Natural Hormones Triggers the Growth of Combination Pills: In terms of types of products, the global oral contraceptive pills market has been divided into progestin-only pills, combination pills, and others. Combination pills are oral contraceptive pills composed of Ethinyl estradiol and progestin that are similar to natural sex hormones progesterone and estrogen produced in a woman’s body. This makes them highly efficient against pregnancy prevention, safer to use, and easily available. The composition pills can have a variable amount of estrogen level. Low level of estrogen causes less bloating or breast tenderness.

Research Report: http://www.transparencymarketresearch.com/oral-contraceptive-pills-market.html

Government Reimbursement Policies in North America Makes Contraceptive Market Growth More Favorable: In terms of geography, the global contraceptive pills market has been categorized into Europe, Latin America, Asia Pacific, North America, and the Middle East and Africa. Increased awareness about contraceptive methods and availability of beneficial reimbursement policies after implementation of the Affordable Care Act has led to the leadership of North America in the global contraceptive pills market.

Improving Economic Condition Makes Asia Pacific Opportunity-Laden Market: Asia Pacific is anticipated to rise with the highest growth rate due to strong economic growth in countries such as Australia, India, China, Philippines, Singapore, and others. High incidences of unwanted pregnancy and rapidly increasing population in countries such as India and China has led to the promotion of contraceptive methods by government and NGOs.

Moreover, the increased use of contraceptive pills to prevent pregnancy after unprotected sex will mark a growth in the oral contraceptive market globally.

Rising Prevalence of Adverse Drug Reactions Drives Global Pharmacovigilance Market

Pharmacovigilance is a crucial part of healthcare and is absolutely vital in improving the accuracy of medicine. Monitoring adverse drug reactions and evaluating the risk posed by the same to the consumers is the ambit of the pharmacovigilance industry. Pharmacovigilance is a continuous process and relies on its continuity to produce progressively more reliable results. The rising awareness about the importance of this process is leading to steady growth of the global pharmacovigilance market.

Browse Research Report: 

http://www.transparencymarketresearch.com/pharmacovigilance-market.html

An NIH study released in February this year evaluated the withdrawal of 462 medicinal products from 1953 to 2013. The report concluded that not only were the reasons for withdrawal inconsistent across the world, but there were several discrepancies in the process as well. The study recommends increased coordination within international agencies and higher transparency in reporting adverse drug reactions to improve the current scenario. A 2012 report by the NIH had also shown that there was a significant increase in the number of people suffering from adverse drug reactions in the U.S. from 1999 to 2006, with rural areas and the geriatric demographic as the key victims.

The pharmacovigilance industry is thus driven by the consistent support provided by such reviews. According to Transparency Market Research, the global pharmacovigilance market was valued at US$2.4 bn in 2013. Exhibiting a robust 14.20% CAGR from 2014 to 2020, the market is expected to rise to a valuation of US$6.1 bn.

Which is the largest product segment of the global pharmacovigilance market?

The global pharmacovigilance is segmented on the basis of clinical trial phase into phase I, phase II, phase III, and post-marketing surveillance. Of these, post-marketing surveillance or phase IV exhibited the highest utilization of pharmacovigilance procedures. 

However, the phase III segment is expected to exhibit the highest CAGR in the forecast period due to the growing realization of the importance of carrying out pharmacovigilance procedures before it is marketed. Clinical studies to remove as much harmful material as possible before the substance is put on the market are becoming increasingly important in the global pharmacovigilance industry. Nevertheless, phase IV will remain the dominant segment of the global pharmacovigilance market, since the effects of a medicinal substance may vary minutely according to the genetic profile of a particular community and can thus only be studied after the substance has been sold.

Which is the largest regional segment of the pharmacovigilance market?

Regionally, North America was the largest market in 2013 and held a 35% share in the global pharmacovigilance market. The North America pharmacovigilance market is driven by the increasing reporting of ADRs and the proactive support to pharmacovigilance practices provided by government healthcare agencies. The high technological sophistication of the healthcare sector in the U.S. and Canada also allows for easy storage of and access to ADR reports.

The Asia Pacific pharmacovigilance market is expected to exhibit the highest growth rate of all regional markets in the forecast period due to the increasing patient pool and the increasing number of clinical trials being conducted in the region. The Asia Pacific market is currently restrained by the widespread of regional alternative medicines, which usually have no provision for an equivalent of pharmacovigilance. However, this restraint is expected to be eradicated by the growing healthcare industry in countries such as India, China, and South Korea.

You can purchase and download the full report here

Increased Consumer Health Awareness Benefits Global Nutraceuticals Market

The extra health benefits provided by the nutraceuticals in addition to the basic nutritional value is giving a push to the global nutraceuticals market. The broad term ranges from isolated nutrients, herbal products and processed foods and beverages, and dietary supplements to specific diets.
They can be considered non-specific biological therapies to provide physiological benefits, ailments to the consumers and relief from numerous chronic diseases. Due to all the aforementioned benefits, a steady growth has been witnessed during past few years and the trend is expected to continue because of an increase in consumer spending habits on nutritious and healthy functional food worldwide.

Changing Lifestyles in Developed Countries Fuel the Demand for Nutraceuticals

A rise in the demand for nutraceuticals is propelled by the increasing awareness for nutritional diet in the developed countries. The U.S.A and Canada, cumulatively, lead the market in 2014 and is anticipated to grow steadily. In Europe, developed countries such as Germany, France, and the U.K have emerged as the key nutraceutical market. Factors such as rising health concerns, and increasing consumer awareness to avoid consuming on synthetic drugs and lead a healthy life are the major contributors to the growth of this market.

Highest Growth Rate in Global Nutraceutical Market Makes APAC Full of Opportunities

While, developed countries are major contributors to the global nutraceutical market, developing countries in the APAC region such as India and China have witnessed growth in the affluent middle-class population, who are shifting towards awareness for nutritional diet. Factors such as the change in lifestyles and increase in income level have enabled them to buy dietary supplements, functional foods, and health drinks. APAC comes second in terms of market share and fastest in terms of growth rate. 

Research Report: http://www.transparencymarketresearch.com/global-nutraceuticals-product-market.html

Nutraceuticals Become Alternative to OTC Drugs and Prescription

The extra health benefits offered by nutraceuticals act as an immunity booster. This quality of the nutraceuticals, per se, help in fighting many acute diseases. The herbal products in the range of nutraceuticals act as a replacement to the OTC Drugs. Nutraceutical ingredients include probiotics and prebiotics, Omega 3, amino acids, fibers, minerals, proteins, structured lipids, vitamins, and various other ingredients. These ingredients help in increasing the metabolism rate, which reduces the necessity of medicine intake.

Smart Devices to Provide Growth Opportunities for Gesture Identification Technologies

The user-friendliness, the human-machine interaction and security promised by the gesture recognition technology are helping it in registering a robust growth. This has led to costumer preference for gesture enabled electronics, including tablets, laptops, and mobile phones. The increasing application of gesture control technology in healthcare, banks, and retail sector are some of the key factors contributing to the rise in global gesture recognition market.

Gesture Technology Makes the Handling of Complex Machines Easier

The market shall witness a major change in the operation and handling of complex machinery with the introduction of gesture control solutions. The complex and bulky machines can be operated remotely with the help of gesture recognition applications. The technology can also help in managing hazardous machines, like reactors from a distance, ensuring safety. The gesture control will also enable automation in the places wherever manual settings were required. 

Automation in the automobile industry through gesture technology will ensure onboard safety and also lift its technology quotient. After the success of touch and voice control, companies are working on the gesture controlled central console of the vehicle.

Research Report: http://www.transparencymarketresearch.com/gesture-recognition-market.html

Gesture Technology Gains Popularity in Gaming Industry

Recent development in the gesture tracking technology and 3D Vision has fueled the demand for gesture technology in the gaming industry. The tracking enabled gaming console coupled with 2D gesture identification technology in smart devices such as PCs, TVs, and tablets are propelling the demand for non-touch, non-voice gesture recognition technology.

Although, limited numbers of recognizable gestures saved in the system is causing a hindrance for the gesture technology to take over the gaming industry. Yet, technological advancements in the gesture recognition market coupled with rising demand for altogether more realistic gaming experience are offering excellent opportunities for the key companies in the gesture recognition market.

Global Clinical Trial Management Systems Market Welcomes the Cloud

Clinical trial management systems (CTMS) are a vital tool in medical research utilized to streamline the data collection process in clinical trials in order to make the data more easily manageable and accessible. In modern times, clinical trial management software is rapidly becoming the norm in the healthcare and pharmaceutical industry due to the increased accuracy and ease of use it provides over conventional methods of data storage. The ever-present need of medicine to have its data refined as finely as possible before clinical utilization has made clinical trial management systems a crucial tool in clinical trial protocol. 

Browse Report: http://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html

The global market for clinical trial management systems is expected to reflect the rising importance of clinical trial management systems in the global healthcare sector, according to Transparency Market Research. The market intelligence firm projects a sturdy 14% CAGR for the global CTMS market from 2013 to 2019, with the market’s valuation expected to rise from US$844 mn to more than US$1.8 bn in that period. 

How influential are cloud-based clinical trial management systems for the global market?

Currently, web-based delivery of clinical trial management systems is the most popular delivery mode. However, the independent storage offered by cloud infrastructure has made cloud-based CTMS the fastest growing segment of the global market. The future of the global CTMS market is likely to feature cloud services prominently, as the global presence of cloud infrastructure improves steadily. 

Recently, global pharmaceutical giant, Pfizer, announced its plans to utilize Oracle’s cloud services across their catalog of more than 300 clinical trials every year. This allows Pfizer to focus its core power into the generation of clinical data and outsource its administration. This is an increasingly popular choice in the global pharmaceutical industry and is likely to play a determinant role in the future of the global clinical trial management systems market in the 2013-2019 forecast period.

How will the increasing investment in life sciences and pharmaceutical research affect the global CTMS market?

The increasing investment in the global pharmaceutical and life sciences sector is a major driver for the global clinical trial management systems market. The need for all kinds of commodities has grown due to the growing global population, while the increasing diversity of demographics and social and economic classes has made healthcare data increasing difficult to track. The increasing pollution and the high prevalence of the almost-stereotypically unhealthy urban lifestyle have also made various lifestyle diseases more prevalent than ever before. This has led to clinical research exhibiting a steady rise all over the world, with the global clinical trial management systems market set to benefit massively from this in the coming years. 

Which is the dominant regional segment of the global CTMS market?

Currently, North America leads the global clinical trial management systems market due to the firm establishment of several pharmaceutical industry giants in the region. However, the expanding Asia Pacific market for pharmaceutical, cosmetic, and nutritional products has made it the dominant force in the global CTMS market. The development of cloud-based smart city infrastructure in leading Asian economies such as China, India, and Japan could thus have a crucial part to play in the development of the region’s clinical trial management systems market.

You can purchase and download the full report here

Global Pain Management Therapeutics Market Restrained by Expiry of Patents, Marketing Exclusivity

Pain management therapeutics are an important class of medicines dealing with reducing and eliminating pain. Pain can originate due to several types of disorders, though tissue damage is the proximal source of pain. The wide-ranging etiology of pain, which medicine treats as a symptom rather than a condition in itself, means that pain management therapeutics have to be similarly versatile, depending on the intensity and the cause of the pain. The debilitating effect of chronic or severe pain on a patient’s quality of life is the primary reason why pain management therapeutics have become so important in modern medicine. 

According to a new report released recently by Transparency Market Research, the global pain management therapeutics market was valued at US$40.9 bn in 2011. The market is expected to exhibit a -5.5% CAGR from 2012 to 2018, ending up at a valuation of close to US$29.5 bn. 

Patent Expirations Restrict Global Pain Management Therapeutics Market

There has been a notable spike in the prevalence of conditions causing chronic pain in the last few decades. Modern phenomena such as the increasing pollution and the increasing adherence to a sedentary lifestyle have contributed to this to no small degree. This has been a major driver for the global pain management therapeutics market and will continue to be a major factor in the market’s growth trajectory in the coming years.

The expected expansion in the availability of healthcare services in emerging countries is also beneficial for the global pain management therapeutics market, as more individuals will be able to get diagnosed with and treated for chronic pain conditions.

However, the expiry of various major products in the global pain management therapeutics market, such as Lyrica (pregabalin) and Cymbalta (duloxetine) – developed by Pfizer and Eli Lilly, respectively – has hurt the prospects of the global market. The loss of marketing exclusivity of these products is likely to result in increased market prospects for generic drug manufacturers. The organized pain management therapeutics market can deal with this restraint by innovating new formulations for pain management, something the industry hasn’t achieved so far.

Browse Report: http://www.transparencymarketresearch.com/pain-management-therapeutics.html

NSAIDs Largest Product Segment, North America Major Regional Market for Pain Management Therapeutics

By product type, the global pain management therapeutics market is segmented into opioids, non-steroidal anti-inflammatory agents (NSAIDs), antidepressants, anti-migraine agents, and anticonvulsants. NSAIDs accounted for the largest share in the global pain management therapeutics market in 2011 and are likely to remain one of the largest segments of the market in the coming years.

Regionally, North America accounted for more than half of the global pain management therapeutics market in 2011, with a valuation of US$21.7 bn. Even though the North America market will remain the largest regional pain management therapeutics market in the coming years, both its valuation and its share in the global market are likely to drop over the forecast period. The North America market for pain management therapeutics is expected to be valued at close to US$14.3 bn by 2018, less than 50% of the global market’s expected 2018 valuation.

Introduction of RNA Analysis Tools and Services to Open Huge Business Prospects in Transcriptomics Technologies

There has been a shift in the focus of pharmaceuticals companies towards targeted therapeutics. This has created a demand for disease-specific biomarkers, which in turn has created opportunities in commercializing transcriptome research outcomes. Transcriptome analysis tools and services help identify novel and potential drug targets. 

Since long, the transcriptomes of stem cells and cancer cells have held the interests of researchers who strive to deeply understand how cellular differentiation or carcinogenesis take place. However, the area of study is expected to expand as researchers are now analyzing the transcriptomes of human embryos, which is expected to be a powerful tool for in vitro fertilization. Transcriptomics is thus, a technology that is continually growing in the field of biomarker discoveries and is extensively used to assess the safety of drugs. 

According to a research report by Transparency Market Research (TMR), the global transcriptomics technologies market will rise from US$1.65 bn in 2012 to US$4.6 bn by the end of 2019 expanding at a healthy CAGR of 15.90% between 2013 and 2019. 

In this blog post, TMR answers three critical questions about the global transcriptomics technologies market:

Q. What are the latest trends in the transcriptomics technologies market?

The transcriptomics technologies market is currently witnessing the partnering of many software companies with life science equipment manufacturers. The partnership is done with a vision to introduce reliable and sophisticated software, which enables easy handling of huge volumes of research data. Thus, it is expected that there will be interdependence between the IT industries and life science equipment manufacturers.

Some of the partnerships and acquisitions between IT companies and life sciences equipment manufacturers include: The acquisition of Ingenuity Systems, Inc., based in the U.S. by Qiagen N.V., has enabled web-based applications to handle the growing volumes of research data. Likewise, DNAStar, Inc., a company headquartered in Madison, has entered into an agreement with Life Technologies Corporation to market its software. 

Another trend, which is emerging in the market, is the mutual collaboration of pharmaceutical companies with research and academic institutions. The outsourcing of research in transcriptomics not only provides a good business opportunity to pharmaceutical companies, but benefits the diagnostic manufacturers as well. Such strategic moves are helping pharmaceutical and in-vitro diagnostics companies to reinforce their business presence and help increase their revenue generation.

Q. What are the challenges that the transcriptomics technologies market is expected to face?

The transcriptomics technologies market is expected to be inhibited by the rising difficulty in the management of complex data. Data complexity increases with the advancements in RNA analysis procedures. For instance, the analysis of the data acquired after the sequencing of multiple transcripts is expected to pose a major concern in transcriptomics research as it generates huge, unmanageable research findings or data. 

Dearth of inefficient data analysis tools will be another challenge impeding the growth of the market. There are very few people who have expertise in the field of transcriptomics technologies. This lack of expertise is preventing the transcriptomics technologies market to grow freely. 

Browse Report: http://www.transparencymarketresearch.com/transcriptomics-technologies-market.html

Q. What does the future hold for transcriptomics technologies?

With the introduction of RNA analysis tools and services, the next generation sequencing platform, huge business prospects are expected to open in transcriptomics research. The increasing demand for precision medicine will lead to a growth in transcriptomics research and also increase the degree of its commercialization. 

The current need for exploiting opportunities in developing novel drug discovery will give rise to assay technologies, multiplexed RNA quantification, and gene expression patterns of specific genes. Thus, the forthcoming era of transcriptomics research is expected to bring rapid advances in the field of drug discovery. As such, the price of new drugs is expected to reduce in the future and most importantly there will be elimination or reduction in the prospect of hypothesis failure. 

Global Cord Blood Banking Services Market Driven by Rising Awareness, Government Support

Cord blood banking refers to blood banks that specialize in storing stem cells from the umbilical cord blood. Cord blood and the stem cells it contains are becoming increasingly important in the global medical scenario due to the ability of stem cells to develop into various types of human cells. This ability has made their use practically imperative in several medical fields that deal with tissue and organ damage. The rising awareness about the utility of cord blood has driven the global cord blood banking services market and will continue to be a major factor in the market’s growth trajectory in the coming years.

According to a market report recently released by Transparency Market Research, the global cord blood banking services market was valued at US$12.4 bn in 2012. Exhibiting a steady 5.60% CAGR from 2013 to 2019, the market is expected to rise to a valuation of US$15.2 bn. 

What are the major drivers for the global cord blood banking services market?

Since cord blood and the stem cells that are a part thereof can only be obtained at the culmination of a pregnancy, making parents more aware of the benefits of cord blood banking has emerged as a major driver for the global market. Several developed countries have been moderately successful in educating a significant part of the population about cord blood banking, which has allowed the market to establish a firm foothold in regions such as North America and Western Europe. Not only is cord blood banking a public good, but having access to cord blood stem cells also increases the chances of the baby’s own successful recovery from various diseases at any point in its life. 

The global cord blood banking services market has also been driven by the rapid technological development observed in the sector, which has led to the process steadily becoming safer and more reliable. This has also been helped by the active role played by various healthcare bodies in spreading awareness about cord blood donation. 

Browse Report: http://www.transparencymarketresearch.com/cord-blood-banking-services.html

Why is it important to support the development of public cord blood banks?

The lack of public cord blood banks on a large scale has held the global cord blood banking services market back. While private cord blood banks store cord blood for use on the individual and their immediate family only, public cord blood banks operate as a network to supply cord blood wherever it is needed – much like a regular blood bank. While private cord blood banks are the more popular type of cord blood banks at present, public banks are expected to steadily increase in number over the next few years due to the growing government support afforded to this field.

Stem cells can help cure some of today’s deadliest and most widely prevalent diseases, such as leukemia, lymphoma, several disorders regarding proliferation of blood, and several congenital disorders. The use of stem cells in treating autoimmune diseases, cardiac diseases, and neurological diseases is also under trial and is likely to come to the fore in the coming years as long as the government support to this sector remains steady.

What are the major regional players in the global cord blood banking services market?

North America dominated the global cord blood banking services market in 2013 and is likely to retain the position over the forecast period. However, Asia Pacific is the market to be for cord blood banking market players in the coming years, as government support to healthcare upgrades is rising in this region and the increasing urban population is becoming both more aware about cord blood banking and capable of paying the relatively high prices of cord blood banking services. As prices level out over the coming years with increasing demand, Asia Pacific could well become the dominant regional market for cord blood banking services.

Reduced Drug Development Costs Steer Pharmaceutical Companies to Develop Companion Diagnostics

Pharmaceutical companies are bearing high costs involved with the development and commercialization of drugs and drug discoveries. Thus, there has been an increased focus by pharmaceutical companies on regulating the costs incurred by means of developing companion diagnostics along with therapeutic drugs. The strategy of co-development allows for the commercial availability of safe and effective drugs and thus, companion diagnostics are expected to materialize as efficient diagnostic tools that will be advantageous for pharmaceutical manufacturers. 

Get Free Sample Research Report: 

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=387

Of late, there has been an increased demand for personalized medicines, which in turn is driving the demand for companion diagnostics, states a research report by Transparency Market Research (TMR). According to the report, the market for companion diagnostics is expected to expand at an 18.1% CAGR from 2013 to 2019.

TMR analysts answer key questions that companies operating in the companion diagnostic market need to ask:

Q. How are companion diagnostics revolutionizing patient care?

Companion diagnostics help eliminate the possibility of side effects by identifying the patients who are most likely to be at risk of several side effects by the use of a particular therapeutic drug.  They identify the patients who are most likely to benefit from a particular therapeutic drug and monitor the response of the patient to a treatment with a particular therapeutic drug. 

Monitoring patients’ response to a medicine is done to enable adjustments in the treatment, for improved effectiveness and safety. For instance, the cobas 4800 BRAF V600 mutation test, which is a companion diagnostic for vemurafenib, helps in the detection of the BRAF V600E mutation in the DNA extracted from human melanoma tissue. Developed by Roche Holdings AG, a Switzerland-based biotech company, the test is intended to be used on selected melanoma patients whose tumors carry the BRAF V600R mutation. 

Q. What are the factors challenging the growth of the companion diagnostics market?

The global companion diagnostics market is hampered to a great extent by prolonged developmental and approval period. The need to have both the drug and the device ready to be launched in the market at the same time, can potentially delay approvals. The delays in approvals of personalized medicines deprive the patients of these medicines for prolonged periods, thus hampering the uptake and sales of companion diagnostics. 

Clinical societies have a huge influence on the acceptance of companion diagnostics by end users. The views and opinions of these societies can affect the market as they impart education by giving biased opinions on their own experience with companion diagnostics. These clinical societies pose as key opinion holders and can alter the preference for companion diagnostics among patients.

Q. What is the progress in the field of companion diagnostics?

Companion diagnostics have been highly successful in the oncology area. This success is encouraging the development of companion diagnostics for other indications such as metabolism disorders, central nervous system (CNS) disorders, and infectious diseases. There have been discoveries of biomarkers for newer indication areas, which is expected to lead to a high growth and increase the revenue generation of the companion diagnostics market.

Case in point, Exosome Diagnostics, Inc. has entered into a collaboration with Takeda Pharmaceuticals International Co. to develop an exosomal RNA sequencing platform for biomarkers. With a goal to develop a platform for serial analysis of gene expression patterns beyond oncology, the analysis of RNAs will provide an innovative tool for patient characterization to select patients. It will then monitor the disease and track the response to the therapeutic drug over the time of the treatment in the patient. This biomarker platform is expected to be an effective therapy for patients not just with cancer but with CNS disorders.

Social Gaming Market Driven by Increasing Use of Smartphones

Social gaming comprises games that can be played on social media websites. These games are often low on graphics, which saves the developer’s costs, but can be played along with one’s friends, which increases its appeal.

Increasing Demand for Smartphone-based Social Gaming to Drive Global Social Gaming Market

The increasing demand for smartphones is a major driver for the global social gaming market. Due to the consistent and rapid technological advancements in the telecom sector, the online functionality of smartphones is being enhanced on a regular basis. This has allowed makers of online games to develop their own product portfolio and add innovative features.

The primarily ad-based revenue generation system of social gaming has also benefitted the global social gaming market, as it has resulted in online games being available to play for free. This is a major driver for the social gaming market in developing regions, where the presence of social media is growing but the disposable income of the consumers remains much lower than that in developed countries.

On the other hand, the restrictions on the usage of social media websites in workplaces are a major restraint on the global social gaming market.

Research Report: http://www.transparencymarketresearch.com/social-gaming-market.html

Women, 19-25 Age Group Emerge as Key Demographics for Social Gaming

 
In terms of the key demographics for the global social gaming market, users in the age group of 19-25 emerged as the key consumers in 2012. By gender, women held the majority in the global social gaming with a 54% share.

Apart from advertising, the in-game sale of virtual goods and lead generation offers are the other two major sources of revenue for the global social gaming market. The virtual goods segment is expected to exhibit a robust growth in demand over the coming years, with the segment expected to exhibit a 15.2% CAGR from 2013 to 2019.

APAC Dominates Global Social Gaming Market

 
By geography, the Asia Pacific social gaming market emerged with the largest share in 2012. The increasing GDP of developing Southeast Asian countries such as Indonesia, Thailand, and Malaysia, and the robust economic performance of regional giants such as India and China have led to an increasing demand for social gaming. The booming smartphone sales in Asia Pacific are also a key contributing factor towards the dominant share of Asia Pacific in the global social gaming market.

The global social gaming market is primarily dominated by Zynga Inc. The early entry of Zynga Inc. into the nascent and risky social gaming market has paid off in the years since then, with social media becoming one of the most easily accessible modes of mass marketing. Electronic Arts Inc., one of the major game developers in the world, is another major player in the global social gaming market.

Food Service Equipment (Commercial Refrigeration) Market Driven by Increasing Demand from Emerging Economies

Commercial refrigeration is a crucial part of any food service, as it allows the vendor to keep the food fresh before selling it. The major driver for the global food service equipment (commercial refrigeration) market is the increasing presence of the hospitality industry. With the increasing availability of urban infrastructure in developed regions and the increasing disposable income of consumers, the hospitality industry is experiencing steady growth all over the world. The increasingly hectic lifestyle of urban consumers is also forcing them to eat out regularly, which is another factor driving the demand for commercial refrigeration services.

Technological Advancement in Food Service Equipment Drives Demand

The advancement in refrigeration technologies over the last few years has also helped the global commercial refrigeration market immensely. The cost-effectiveness of food service equipment has become increasingly important for the hospitality industry due to its direct impact on the company’s profit margins, driving the demand for advanced commercial refrigeration products.

Research Report: http://www.transparencymarketresearch.com/food-service-equipment.html

High Installation Costs Restrict Use of Food Service Equipment

However, the prohibitively high capital investment required to install top-notch food service equipment has restrained the growth of the global market. While large international players can afford to install advanced commercial refrigeration services, new players have to make do with older technology. This is a key restraint on the global food service equipment market, but is likely to be ameliorated over the forecast period.

Walk Ins Dominate Global Commercial Refrigeration Market

Walk ins held the largest share in the revenue of the global food service equipment market in 2014. Walk ins are preferred by vendors due to the higher convenience they provide to customers and accounted for close to one million commercial refrigeration units in 2013. Even though walk ins are expected to remain the leading segment of the global commercial refrigeration equipment market till 2020, the beverage dispensers segment is likely to exhibit the highest growth rate of all product segments. Other major product types in the global commercial refrigeration market include ice machines, glass door merchandisers, refrigerated vending machines, commercial fridges/freezers, ice cream cabinets, and blast freezers.